Delivery Order SPE2DB22D3501-SPE2DB24FXA95

Award Date 9/23/24
Potential Completion Date 9/24/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,963.48 to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide BREVIBLOC 2,000 MG/100 ML BAG 100ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,737.03, is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML, a medical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 15, 2023. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,156.27, is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML medical supplies. The contract is a Firm Fixed Price Delivery Order that runs through April 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,711.16 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4563501675 BREVIBLOC 2,500 MG/250 ML BAG 250ML. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
This federal contract award, valued at $2,289.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML, a medical product, with a period of performance ending on September 3, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Bridion 200 mg/2 ml vial (2 ml). The contract is a firm fixed-price delivery order with a ceiling value of $16,154.29 and a period of performance through April 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,717.47, is for the delivery of Bridion 200mg/2ml, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period extending through May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $26,287.61 firm fixed price contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products. The order has an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $4,101.96, is for the supply of the pharmaceutical product Bridion 200 mg/2 ml vial. The delivery order has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the sole prime contractor on this delivery...
This is a $5,732.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for BRIDION 200 MG/2 ML VIAL 2ML medical supplies, with a period of performance through January 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FXA95
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of BREVIBLOC 2,000 MG/100 ML BAG 100ML, a pharmaceutical product. The delivery order is valued at $9,995.45 and has a firm fixed price. The contract does not have a set-aside designation.

AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and supplies, to support military treatment programs and facilities worldwide.

Generated 12/23/24, 2:37 PM